Our data strongly suggest that MSP, via its receptor RON, activates the downstream AMPK signaling pathway, in turn inhibiting inflammation and excessive lipid accumulation and, thereby, having a crucial role in countering NASH. This evidence concerns the gene MST1R and metabolic dysfunction-associated steatohepatitis.